Posted: March 16, 2026
Elizabeth Mihal, Scientific Product Manager Recently, it seems as if women of a certain age are inundated with ads for weighted vests and social media posts about balancing hormones. After decades of health research focusing on clinical trial data that have predominantly used male subjects, recent efforts to promote women’s health can be lauded. However,
Posted: December 30, 2025
Jennifer J. Kiblinger, Scientific Director The ASH 2025 meeting offered a mix of innovation and ongoing debates, highlighting exciting developments in hemophilia treatment, anticoagulation strategies, and novel approaches to hemostasis. Some highlights for me: And of course, one of the cutest highlights – the Puppy Playground! Attendees could snuggle and play with puppies during the
Posted: June 27, 2025
See what we unveiled at ISTH 2025! VIEW VIDEO We are grateful for the opportunity to connect and discuss the latest advancements for the hemostasis laboratory at ISTH 2025. The science and collaboration were outstanding. Many thanks to all who worked so hard to make it a success! DiaPharma was proud to highlight: CLINICAL &
Posted: March 31, 2025
— Contributed by Olivia Stricker, PhD and Jessica Tuohy, PhD The 2025 AASLD Emerging Topics Conference in Las Vegas delivered an invigorating discussion on one of the most pressing challenges in hepatology today—metabolic dysfunction-associated alcohol-related liver disease (metALD) and the evolving landscape of ALD clinical trials. As research advances, our understanding of these diseases continues
Posted: September 12, 2024
It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the cytokeratin 18 (CK18) biomarker assays, M30® Apoptosense and M65 ELISA®, for MASH, ALD/AH, DILI , or any of our other cutting edge products? Make
Posted: September 11, 2024
It’s Not Just Support. It’s Solutions. VISIT DIAPHARMA AT THESE UPCOMING EVENTS! Connect with DiaPharma to discuss all the latest in hemostasis and liver disease. Interested in learning more about the Ceveron s100*, the FDA-cleared T-TAS 01, Technozym ADAMTS13 Activity ELISA for IVD use, M30® Apoptosense ELISA for liver damage, or any of our other